Develops, manufactures and markets a line of innovative, technologically enhanced PVC-free and latex-free urinary continence and urine drainage care products for the extended care and acute care markets.
The best Bull and Bear pitches based on recency and number of recommendations.
Stock has pulled back to the $24 range where it has value. Aging population spells long term growth for their medical (catheter) business. Look for continued earnings/revenue growth over next two years - volatile, but good chance to outperform.
my beliefs here are that we have a nice company , but the stats show this to be over bought and we should try to find an entry point that would be more suitable . wait for a sell off and keep an eye on performace in the mean time.
Read the most recent pitches from players about ROCM.DL.
Find the members with the highest scoring picks in ROCM.DL.
See what the Wall Street professionals think, according to their public statements and filings.